Plasmonic Photothermal and Stem Cell Therapy of Atherosclerosis With The Use of Gold Nanoparticles With Iron Oxide-Silica Shells Versus Stenting

Trial Profile

Plasmonic Photothermal and Stem Cell Therapy of Atherosclerosis With The Use of Gold Nanoparticles With Iron Oxide-Silica Shells Versus Stenting

Discontinued
Phase of Trial: Phase I

Latest Information Update: 31 Jul 2015

At a glance

  • Drugs Everolimus (Primary) ; Stem cell therapies
  • Indications Angina pectoris; Atherosclerosis; Coronary artery disease
  • Focus Therapeutic Use
  • Acronyms NANOM-PCI
  • Most Recent Events

    • 01 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 29 Jun 2012 Actual initiation date changed from Dec 2011 to Dec 2010 as reported by ClinicalTrials.gov.
    • 29 Jun 2012 Planned End Date changed from 1 Feb 2014 to 1 Nov 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top